Insulin glargine and lixisenatide Subcutaneous and Lopinavir and Ritonavir Solution
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Lopinavir and Ritonavir Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: lopinavir / ritonavir
Brand name: Kaletra
Synonyms: Lopinavir and ritonavir, Lopinavir and Ritonavir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Lopinavir and Ritonavir Tablets
- Insulin glargine and lixisenatide Subcutaneous-Lopreeza
- Insulin glargine and lixisenatide Subcutaneous-Lopressor
- Insulin glargine and lixisenatide Subcutaneous-Lopressor (Metoprolol Injection)
- Insulin glargine and lixisenatide Subcutaneous-Lopressor (Metoprolol Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Lopressor HCT
- Lopinavir and Ritonavir Solution-Insulin glargine, recombinant Subcutaneous
- Lopinavir and Ritonavir Solution-Insulin glulisine
- Lopinavir and Ritonavir Solution-Insulin Glulisine (Cartridges and Pens)
- Lopinavir and Ritonavir Solution-Insulin Glulisine (Vials)
- Lopinavir and Ritonavir Solution-Insulin glulisine Subcutaneous
- Lopinavir and Ritonavir Solution-Insulin human inhaled Inhalation